메뉴 건너뛰기




Volumn 49, Issue 4, 2011, Pages 695-698

High frequency of inadequate test requests for antiphospholipid antibodies in daily clinical practice

Author keywords

anti 2 glycoprotein I antibodies; anti cardiolipin antibodies; Dilute Russell's viper venom time (dRVVT); inadequate test request; silica clotting time (SCT)

Indexed keywords

BETA2 GLYCOPROTEIN 1; CARDIOLIPIN ANTIBODY; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY;

EID: 79954471954     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2011.111     Document Type: Article
Times cited : (8)

References (12)
  • 1
    • 0034917281 scopus 로고    scopus 로고
    • Antiphospholipid syndrome: Diagnostic aspects of lupus anticoagulants
    • Arnout J. Antiphospholipid syndrome: diagnostic aspects of lupus anticoagulants. J Thromb Haemost 2001;86:83-91. (Pubitemid 32663940)
    • (2001) Thrombosis and Haemostasis , vol.86 , Issue.1 , pp. 83-91
    • Arnout, J.1
  • 2
    • 33344458573 scopus 로고    scopus 로고
    • International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
    • Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006;4:295-306.
    • (2006) J Thromb Haemost , vol.4 , pp. 295-306
    • Miyakis, S.1    Lockshin, M.D.2    Atsumi, T.3    Branch, D.W.4    Brey, R.L.5    Cervera, R.6
  • 3
    • 70749098237 scopus 로고    scopus 로고
    • The interplay between the antiphospholipid syndrome and systemic lupus erythematosus
    • Tincani A, Andreoli L, Chighizola C, Meroni PL. The interplay between the antiphospholipid syndrome and systemic lupus erythematosus. Autoimmunity 2009;42:257-9.
    • (2009) Autoimmunity , vol.42 , pp. 257-9
    • Tincani, A.1    Andreoli, L.2    Chighizola, C.3    Meroni, P.L.4
  • 4
    • 62749176416 scopus 로고    scopus 로고
    • Testing for lupus anticoagulants: All that a clinician should know
    • Tripodi A. Testing for lupus anticoagulants: all that a clinician should know. Lupus 2009;18:291-8.
    • (2009) Lupus , vol.18 , pp. 291-8
    • Tripodi, A.1
  • 6
    • 53049099468 scopus 로고    scopus 로고
    • Laboratory testing and identification of antiphospholipid antibodies and the antiphospholipid syndrome: A potpourri of problems, a compilation of possible solu-tions
    • Favaloro EJ, Wong RC. Laboratory testing and identification of antiphospholipid antibodies and the antiphospholipid syndrome: a potpourri of problems, a compilation of possible solu-tions. Semin Thromb Hemost 2008;34:389-410.
    • (2008) Semin Thromb Hemost , vol.34 , pp. 389-410
    • Favaloro, E.J.1    Wong, R.C.2
  • 7
    • 34547411070 scopus 로고    scopus 로고
    • Non-evidence-based variables affecting physicians' test-ordering tendencies: A systematic review
    • Sood R, Sood A, Ghosh AK. Non-evidence-based variables affecting physicians' test-ordering tendencies: a systematic review. Neth J Med 2007;65:167-77. (Pubitemid 47161618)
    • (2007) Netherlands Journal of Medicine , vol.65 , Issue.5 , pp. 167-177
    • Sood, R.1    Sood, A.2    Ghosh, A.K.3
  • 8
    • 0141958839 scopus 로고    scopus 로고
    • Anti-β2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome
    • DOI 10.1182/blood-2002-11-3334
    • Galli M, Luciani D, Bertolini G, Barbui T. Anti-beta 2-glyco-protein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome. Blood 2003;102:2717-23. (Pubitemid 37248837)
    • (2003) Blood , vol.102 , Issue.8 , pp. 2717-2723
    • Galli, M.1    Luciani, D.2    Bertolini, G.3    Barbui, T.4
  • 9
    • 0037370733 scopus 로고    scopus 로고
    • Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: A systematic review of the literature
    • DOI 10.1182/blood-2002-02-0441
    • Galli M, Luciani D, Bertolini G, Barbui T. Lupus anticoagu-lants are stronger risk factors for thrombosis than anticardioli-pin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood 2003;101:1827-32. (Pubitemid 36237580)
    • (2003) Blood , vol.101 , Issue.5 , pp. 1827-1832
    • Galli, M.1    Luciani, D.2    Bertolini, G.3    Barbui, T.4
  • 10
    • 84993674548 scopus 로고    scopus 로고
    • Do we know what inappropriate lab-oratory utilization is?
    • Walraven C, Naylor CD. Do we know what inappropriate lab-oratory utilization is? J Am Med Assoc 1998;280:550-8.
    • (1998) J Am Med Assoc , vol.280 , pp. 550-8
    • Walraven, C.1    Naylor, C.D.2
  • 11
    • 0029938665 scopus 로고    scopus 로고
    • Strategies to promote rational clinical chemistry test utilization
    • DOI 10.1016/0009-9120(96)00042-2
    • Hindmarsh JT, Lyon AW. Strategies to promote rational clinical chemistry test utilization. Clin Biochem 1996;29:291-9. (Pubitemid 26249694)
    • (1996) Clinical Biochemistry , vol.29 , Issue.4 , pp. 291-299
    • Hindmarsh, J.T.1    Lyon, A.W.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.